| Dr Robert A Corish, MD | |
|
8901 W Lincoln Ave, West Allis, WI 53227-2409 | |
| (414) 328-6000 | |
| Not Available |
| Full Name | Dr Robert A Corish |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 33 Years |
| Location | 8901 W Lincoln Ave, West Allis, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194708008 | NPI | - | NPPES |
| 31911300 | Medicaid | WI | |
| 42035 | Other | FL | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | ME86974 (Florida) | Secondary |
| 207L00000X | Anesthesiology | 34044-020 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Mary's Hospital Medical Center | Green bay, WI | Hospital |
| Aurora St Lukes Medical Center | Milwaukee, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Green Bay Anesthesia Assoc. Sc | 4486613858 | 78 |
| Aurora Medical Group, Inc. | 6709794258 | 3207 |
News Archive
The U.S. Agriculture Department has confirmed that an Alabama cow suspected of having mad cow disease, did have the fatal brain disease.
...especially when learning takes place in an informal, interactive discussion group setting, according to a new review of studies.
A new drive to harness the research potential of the NHS was given a further boost today by the creation of the UK Clinical Research Collaboration (UKCRC).
ChemoCentryx, Inc. today announced that it has begun enrolling patients in a Phase 2 clinical trial of CCX354, an orally-bioavailable, novel, small molecule drug designed to specifically target the CCR1 chemokine receptor for the treatment of rheumatoid arthritis (RA).
› Verified 9 days ago
| Entity Name | Aurora Medical Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427271378 PECOS PAC ID: 6709794258 Enrollment ID: O20031105000725 |
News Archive
The U.S. Agriculture Department has confirmed that an Alabama cow suspected of having mad cow disease, did have the fatal brain disease.
...especially when learning takes place in an informal, interactive discussion group setting, according to a new review of studies.
A new drive to harness the research potential of the NHS was given a further boost today by the creation of the UK Clinical Research Collaboration (UKCRC).
ChemoCentryx, Inc. today announced that it has begun enrolling patients in a Phase 2 clinical trial of CCX354, an orally-bioavailable, novel, small molecule drug designed to specifically target the CCR1 chemokine receptor for the treatment of rheumatoid arthritis (RA).
› Verified 9 days ago
| Entity Name | Milwaukee Anesthesiology Consultants Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902852098 PECOS PAC ID: 1254312242 Enrollment ID: O20040526000517 |
News Archive
The U.S. Agriculture Department has confirmed that an Alabama cow suspected of having mad cow disease, did have the fatal brain disease.
...especially when learning takes place in an informal, interactive discussion group setting, according to a new review of studies.
A new drive to harness the research potential of the NHS was given a further boost today by the creation of the UK Clinical Research Collaboration (UKCRC).
ChemoCentryx, Inc. today announced that it has begun enrolling patients in a Phase 2 clinical trial of CCX354, an orally-bioavailable, novel, small molecule drug designed to specifically target the CCR1 chemokine receptor for the treatment of rheumatoid arthritis (RA).
› Verified 9 days ago
| Entity Name | Green Bay Anesthesia Assoc. Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023065836 PECOS PAC ID: 4486613858 Enrollment ID: O20041011000244 |
News Archive
The U.S. Agriculture Department has confirmed that an Alabama cow suspected of having mad cow disease, did have the fatal brain disease.
...especially when learning takes place in an informal, interactive discussion group setting, according to a new review of studies.
A new drive to harness the research potential of the NHS was given a further boost today by the creation of the UK Clinical Research Collaboration (UKCRC).
ChemoCentryx, Inc. today announced that it has begun enrolling patients in a Phase 2 clinical trial of CCX354, an orally-bioavailable, novel, small molecule drug designed to specifically target the CCR1 chemokine receptor for the treatment of rheumatoid arthritis (RA).
› Verified 9 days ago
| Entity Name | Bellin Anesthesia Associates Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558318410 PECOS PAC ID: 1254357684 Enrollment ID: O20051014000796 |
News Archive
The U.S. Agriculture Department has confirmed that an Alabama cow suspected of having mad cow disease, did have the fatal brain disease.
...especially when learning takes place in an informal, interactive discussion group setting, according to a new review of studies.
A new drive to harness the research potential of the NHS was given a further boost today by the creation of the UK Clinical Research Collaboration (UKCRC).
ChemoCentryx, Inc. today announced that it has begun enrolling patients in a Phase 2 clinical trial of CCX354, an orally-bioavailable, novel, small molecule drug designed to specifically target the CCR1 chemokine receptor for the treatment of rheumatoid arthritis (RA).
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert A Corish, MD 8901 W Lincoln Ave, West Allis, WI 53227-2409 Ph: (414) 328-6000 | Dr Robert A Corish, MD 8901 W Lincoln Ave, West Allis, WI 53227-2409 Ph: (414) 328-6000 |
News Archive
The U.S. Agriculture Department has confirmed that an Alabama cow suspected of having mad cow disease, did have the fatal brain disease.
...especially when learning takes place in an informal, interactive discussion group setting, according to a new review of studies.
A new drive to harness the research potential of the NHS was given a further boost today by the creation of the UK Clinical Research Collaboration (UKCRC).
ChemoCentryx, Inc. today announced that it has begun enrolling patients in a Phase 2 clinical trial of CCX354, an orally-bioavailable, novel, small molecule drug designed to specifically target the CCR1 chemokine receptor for the treatment of rheumatoid arthritis (RA).
› Verified 9 days ago
Dr. Daniel M Smullen, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 8901 W Lincoln Ave, 2nd Fl, West Allis, WI 53227 Phone: 414-329-4300 | |
Dr. Nathan Paul Gabler, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 8901 W Lincoln Ave, West Allis, WI 53227 Phone: 414-328-6000 Fax: 414-328-8536 | |
Nicholas Edward Foster, Anesthesiology Medicare: Medicare Enrolled Practice Location: 8901 W Lincoln Ave, West Allis, WI 53227 Phone: 414-328-6000 Fax: 414-649-1328 | |
Dr. Lily Qian, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 8901 W Lincoln Ave, West Allis, WI 53227 Phone: 414-328-6000 | |
Kirsten J Simanonok, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 8901 W Lincoln Ave, West Allis, WI 53227 Phone: 414-328-6000 | |
Dr. Eduards J Vucins, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 8901 W Lincoln Ave, West Allis, WI 53227 Phone: 414-328-6000 |